The U.S. Food and Drug Administration issued a notice Wednesday that it will give people more chances to comment on the question of dropping cannabis from the most restricted class of drugs for the purposes of international treaties.
An unpublished notice was filed Wednesday by the FDA in the Federal Register indicating it will officially open comments on the issue on Thursday. The public will then have 30 days to submit comments electronically or by mail on the question of “rescheduling” cannabis.
Cannabis currently is in the category of the most controlled substances under a 1961 international treaty, deemed to be more dangerous than any therapeutic benefits are worth.
While there are skeptics, much of the medical community in recent years has come to think of cannabis as having legitimate medical uses, potentially significant ones.
Rescheduling the drug under international treaties wouldn’t make cannabis immediately legal in the United States, where it remains federally prohibited, even though it’s legal in certain states. But it would be considered a step toward further government acceptance of its medical potential.
The FDA move is in response to an ongoing review of the drug classification system by the United Nations. The UN’s World Health Organization has recommended rescheduling cannabis.
Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.